Complicated Cystitis Treatment Guidelines

First-Line Treatment Options

• The Infectious Diseases Society of America recommends ciprofloxacin 500mg twice daily for 7 days as the preferred first-line treatment for complicated cystitis when local resistance rates are below 10% 1, 2
• For outpatient treatment where fluoroquinolone resistance is <10%, the American College of Physicians suggests extended-release ciprofloxacin 1000mg once daily for 7 days or levofloxacin 750mg once daily for 5 days 2
• When fluoroquinolone resistance is >10%, the Infectious Diseases Society of America recommends adding an initial one-time parenteral dose of ceftriaxone 1g IV or a consolidated 24-hour dose of an aminoglycoside 1, 2

Alternative Treatment Options

• The American College of Physicians recommends trimethoprim-sulfamethoxazole (160/800mg twice daily for 14 days) as an alternative treatment option when the uropathogen is known to be susceptible 2, 3
• Oral β-lactams are less effective than other agents for complicated UTIs, but can be used in combination with an initial IV dose of ceftriaxone 1g or aminoglycoside, with a treatment duration of 10-14 days 1, 2

Important Clinical Considerations

• The Infectious Diseases Society of America recommends obtaining urine culture and susceptibility testing in complicated cystitis to guide therapy, and tailoring initial empiric therapy based on local resistance patterns 1, 2
• Therapy should be adjusted based on culture results when available, and longer treatment durations are typically required for patients with structural or functional abnormalities of the urinary tract compared to uncomplicated cystitis 1, 3

Common Pitfalls to Avoid

• The American College of Physicians advises against using fluoroquinolones empirically when local resistance rates exceed 10% without adding an initial parenteral antibiotic, and against using trimethoprim-sulfamethoxazole empirically without knowledge of susceptibility patterns 1, 2, 3
• The Infectious Diseases Society of America recommends avoiding the use of amoxicillin or ampicillin as empiric therapy due to poor efficacy and high resistance rates, and failing to obtain cultures in complicated UTIs 1, 2, 4